Haußmann R, Homeyer P, Donix M, Linn J
Universitäts DemenzCentrum (UDC), Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Deutschland.
DZNE, Deutsches Zentrum für Neurodegenerative Erkrankungen, Dresden, Deutschland.
Nervenarzt. 2022 Jun;93(6):605-611. doi: 10.1007/s00115-021-01213-x. Epub 2021 Oct 15.
Cerebral amyloid angiopathy (CAA) is closely related to Alzheimer's disease (AD) despite having distinct pathomechanisms. The CAA modulates cognitive impairment within AD by synergistic effects. The pathophysiologic relations are complex and incompletely understood, possibly due to the heterogeneous nature of CAA with its different subtypes. Both diseases are characterized by a pathologic amyloid metabolism but the pathologic processing of amyloid precursor proteins is distinct. The manifestation of vascular and parenchymal amyloid deposits can either overlap or occur independently and isolated. The investigation of the specific contribution of co-occurring CAA within AD to cognitive deficits requires diagnostic methods that sufficiently identify CAA severity and complexity as well as detailed neuropsychological testing to precisely characterize the cognitive deficits and to draw conclusions regarding their etiology.
尽管脑淀粉样血管病(CAA)与阿尔茨海默病(AD)具有不同的发病机制,但二者密切相关。CAA通过协同作用调节AD患者的认知障碍。其病理生理关系复杂且尚未完全明确,这可能是由于CAA不同亚型具有异质性。两种疾病均以病理性淀粉样蛋白代谢为特征,但淀粉样前体蛋白的病理加工过程有所不同。血管和实质淀粉样蛋白沉积的表现可能重叠,也可能独立出现。研究AD中共存的CAA对认知缺陷的具体影响,需要能够充分识别CAA严重程度和复杂性的诊断方法,以及详细的神经心理学测试,以精确描述认知缺陷并推断其病因。